These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 14636948

  • 1. Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis.
    Alexander JJ, Bao L, Jacob A, Kraus DM, Holers VM, Quigg RJ.
    Biochim Biophys Acta; 2003 Nov 20; 1639(3):169-76. PubMed ID: 14636948
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis.
    Alexander JJ, Jacob A, Bao L, Macdonald RL, Quigg RJ.
    J Immunol; 2005 Dec 15; 175(12):8312-9. PubMed ID: 16339572
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Curcumin aggravates CNS pathology in experimental systemic lupus erythematosus.
    Foxley S, Zamora M, Hack B, Alexander RR, Roman B, Quigg RJ, Alexander JJ.
    Brain Res; 2013 Apr 04; 1504():85-96. PubMed ID: 23410788
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice.
    Atkinson C, Qiao F, Song H, Gilkeson GS, Tomlinson S.
    J Immunol; 2008 Jan 15; 180(2):1231-8. PubMed ID: 18178863
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.
    Wen J, Doerner J, Weidenheim K, Xia Y, Stock A, Michaelson JS, Baruch K, Deczkowska A, Gulinello M, Schwartz M, Burkly LC, Putterman C.
    J Autoimmun; 2015 Jun 15; 60():40-50. PubMed ID: 25911200
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. C5a alters blood-brain barrier integrity in experimental lupus.
    Jacob A, Hack B, Chiang E, Garcia JG, Quigg RJ, Alexander JJ.
    FASEB J; 2010 Jun 15; 24(6):1682-8. PubMed ID: 20065106
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice.
    Huang MW, Stock AD, Putterman C.
    Front Immunol; 2021 Jun 15; 12():763065. PubMed ID: 34868008
    [Abstract] [Full Text] [Related]

  • 19. MRL/lpr mice have alterations in brain metabolism as shown with [1H-13C] NMR spectroscopy.
    Alexander JJ, Zwingmann C, Quigg R.
    Neurochem Int; 2005 Jul 15; 47(1-2):143-51. PubMed ID: 15893408
    [Abstract] [Full Text] [Related]

  • 20. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.